Esculentoside A Inhibits Lung Cancer Cell Migration and Invasion by Modulating Macrophage Polarization through IL-6/STAT3 Signaling Pathway

被引:0
|
作者
Li, Yanhong [1 ]
Li, Yanli [2 ]
Zhou, Qin [1 ]
Dong, Yuanyuan [1 ]
Zhang, Yan [1 ]
Zhu, Jianyong [1 ,3 ]
机构
[1] Hubei Univ Med, Renmin Hosp, Dept Pulm &Crit Care Med, Shiyan 442000, Hubei, Peoples R China
[2] Danjiangkou First Hosp, Dept Endocrine, Shiyan 442700, Hubei, Peoples R China
[3] Shinshu Univ, Sch Med, Dept Cardiovasc Res, Matsumoto 3908621, Japan
关键词
Esculentoside A; macrophage polarization; STAT3; lung cancer; TUMOR-ASSOCIATED MACROPHAGES; LIPOPOLYSACCHARIDE; INFLAMMATION; ACTIVATION;
D O I
10.23812/j.biol.regul.homeost.agents.20243801.23
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Tumor-associated macrophage (TAM) is pivotal in cancer progression. Esculentoside A (EsA) is a saponin extracted from plants, which has anti-cancer and anti-inflammatory effects. However, its anti-cancer effects through inhibiting TAM activation are still unclear and need further research.Methods: Human myeloid leukemia mononuclear cells (THP-1) differentiate into M2 macrophages under induction. The culti-vation of A549 and H1299 cells was performed in a conditioned medium from M2 macrophages (M2-CM) to fathom the effects of EsA on viability of cancer cells and their abilities to migrate and invade. The macrophage markers were measured by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and flow cytometry. Investigations on how EsA impacts interleukin (IL)-6/signal transducer and activator of transcription 3 (STAT3) signaling pathway were conducted by means of western blot and immunofluorescence.Results: Adherent and rounded THP-1 cells were observed through propidium monoazide (PMA) treatment. THP-1 cells ex-pressed M1 macrophage markers with induction of lipopolysaccharide/interferon--y and expressed M2 macrophage markers after induction of IL-13/IL-4 (p < 0.01). EsA may dampen IL-13/IL-4-induced M2 macrophage polarization as indicated by downreg-ulation of the mRNA levels of CD206 (M2 macrophage marker) and peroxisome proliferator-activated receptor-y (PPAR-y) (p < 0.001), and inhibit IL-6 expression in cells and STAT3 phosphorylation (p < 0.05). Moreover, EsA reversed M2-CM-induced promotion of lung cancer cell migration and invasion (p < 0.05).Conclusions: EsA inhibits lung cancer cell migration and invasion by mediating macrophage polarization through IL-6/STAT3 signaling pathway.
引用
下载
收藏
页码:293 / 301
页数:9
相关论文
共 50 条
  • [21] γ-Tocotrienol inhibits T helper 17 cell differentiation via the IL-6/JAK/STAT3 signaling pathway
    Zhao, Hanqing
    Guo, Xin
    Lei, Yunxuan
    Xia, Wenjie
    Cai, Feiyang
    Zhu, Dehao
    An, Yang
    Xi, Yebin
    Niu, Xiaoyin
    Wang, Zhaojun
    Yue, Tao
    Chen, Guangjie
    MOLECULAR IMMUNOLOGY, 2022, 151 : 126 - 133
  • [22] Astragaloside IV inhibits the progression of liver cancer by modulating macrophage polarization through the TLR4/NF-κB/STAT3 signaling pathway
    Min, Liang
    Wang, Haibiao
    Qi, Hong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (03): : 1551 - 1566
  • [23] Icariside I reduces breast cancer proliferation, apoptosis, invasion, and metastasis probably through inhibiting IL-6/STAT3 signaling pathway
    Hou, Manting
    Li, Hui
    He, Tingting
    Hui, Siwen
    Dai, Wenzhang
    Hou, Xiaorong
    Zhao, Jing
    Zhao, Jia
    Wen, Jincai
    Kan, Wen
    Xiao, Xiaohe
    Zhan, Xiaoyan
    Bai, Zhaofang
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2024, 76 (05) : 499 - 513
  • [24] Icaritin inhibits glioblastoma cell viability and glycolysis by blocking the IL-6/Stat3 pathway
    Li, Hongchao
    Liang, Qinghua
    Wang, Lin
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (05) : 7257 - 7264
  • [25] Aspirin Inhibits Carcinogenesis of Intestinal Mucosal Cells in UC Mice Through Inhibiting IL-6/JAK/STAT3 Signaling Pathway and Modulating Apoptosis and Proliferation
    Chen, Yingying
    Sun, Liying
    Li, Dongyue
    Yin, Xunhai
    Shang, Guoyin
    Diao, Tiantian
    Shi, Lijun
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2022, 33 (09): : 731 - 742
  • [26] Kang-Ai Injection Inhibits Gastric Cancer Cells Proliferation through IL-6/STAT3 Pathway
    ZHENG Chun-lei
    HOU Ke-zuo
    WANG An-qi
    FANG Wan-xia
    YU Shi-tong
    LIANG Jin-e
    QI Hai-yan
    QU Xiu-juan
    LIU Yun-peng
    CHE Xiao-fang
    Chinese Journal of Integrative Medicine, 2022, 28 (06) : 524 - 530
  • [27] Kang-Ai Injection Inhibits Gastric Cancer Cells Proliferation through IL-6/STAT3 Pathway
    ZHENG Chunlei
    HOU Kezuo
    WANG Anqi
    FANG Wanxia
    YU Shitong
    LIANG Jine
    QI Haiyan
    QU Xiujuan
    LIU Yunpeng
    CHE Xiaofang
    Chinese Journal of Integrative Medicine , 2022, (06) : 524 - 530
  • [28] Kang-Ai Injection Inhibits Gastric Cancer Cells Proliferation through IL-6/STAT3 Pathway
    Chun-lei Zheng
    Ke-zuo Hou
    An-qi Wang
    Wan-xia Fang
    Shi-tong Yu
    Jin-e Liang
    Hai-yan Qi
    Xiu-juan Qu
    Yun-peng Liu
    Xiao-fang Che
    Chinese Journal of Integrative Medicine, 2022, 28 : 524 - 530
  • [30] Progress in Understanding the IL-6/STAT3 Pathway in Colorectal Cancer
    Lin, Yan
    He, Ziqin
    Ye, Jiazhou
    Liu, Ziyu
    She, Xiaomin
    Gao, Xing
    Liang, Rong
    ONCOTARGETS AND THERAPY, 2020, 13 : 13023 - 13032